title: Comparison of Azithromycin and Amoxicillin Before Dental Implant Placement: An Exploratory Study of Bioavailability and Resolution of Postoperative Inflammation.
abstract: BACKGROUND
  Studies suggest that a single prophylactic dose of amoxicillin reduces early implant complications, but it is unclear whether other antibiotics are also effective. This study compared the local antimicrobial and anti-inflammatory effects resulting from a single dose of azithromycin or amoxicillin before surgical placement of one-stage dental implants.
  
  
  METHODS
  Healthy adult patients requiring one-stage dental implant placement were allocated randomly to receive either 2 g amoxicillin (n = 7) or 500 mg azithromycin (n = 6) before surgery. Peri-implant crevicular fluid (PICF) samples from the new implant and gingival crevicular fluid (GCF) from adjacent teeth were sampled on postoperative days 6, 13, and 20. Inflammatory mediators in the samples were analyzed by immunoassay, and antibiotic levels were measured by bioassay.
  
  
  RESULTS
  On day 6, azithromycin concentrations in GCF and PICF were 3.39 ± 0.73 and 2.77 ± 0.90 μg/mL, respectively, whereas amoxicillin was below the limit of detection. During early healing, patents in the azithromycin group exhibited a significantly greater decrease in GCF volume (P = 0.03, analysis of variance). At specific times during healing, the azithromycin group exhibited significantly lower levels of interleukin (IL)-6 and IL-8 in GCF than the amoxicillin group and exhibited significantly lower levels of granulocyte colony stimulating factor, IL-8, macrophage inflammatory protein-1β, and interferon-gamma-inducible protein-10 in PICF.
  
  
  CONCLUSIONS
  Azithromycin was available at the surgical site for a longer period of time than amoxicillin, and patients taking azithromycin exhibited lower levels of specific proinflammatory cytokines and chemokines in GCF and PICF. Thus, preoperative azithromycin may enhance resolution of postoperative inflammation to a greater extent than amoxicillin.
authors.affiliation: Division of Periodontology, College of Dentistry, The Ohio State University Wexner Medical Center, Columbus, OH.
authors.forename: Mariana Gil
authors.initials: MG
authors.lastname: Escalante
authors.affiliation: Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine; Department of Internal Medicine; The Ohio State University Wexner Medical Center.
authors.forename: Tim D
authors.initials: TD
authors.lastname: Eubank
authors.affiliation: Division of Periodontology, College of Dentistry, The Ohio State University Wexner Medical Center, Columbus, OH.
authors.forename: Binnaz
authors.initials: B
authors.lastname: Leblebicioglu
authors.affiliation: Division of Periodontology, College of Dentistry, The Ohio State University Wexner Medical Center, Columbus, OH.
authors.forename: John D
authors.initials: JD
authors.lastname: Walters
mesh_terms: D000328:Adult; D000658:Amoxicillin / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017963:Azithromycin / Q000627:therapeutic use*; D001682:Biological Availability; D015921:Dental Implants; D005883:Gingival Crevicular Fluid; D006801:Humans; D007249:Inflammation / Q000517:prevention & control*
chemical_list: D000900:Anti-Bacterial Agents; D015921:Dental Implants; D000658:Amoxicillin; D017963:Azithromycin
keywords: Antibiotic prophylaxis; chemokines; cytokines; inflammation; wound healing